drugset / Trial / NCT01981928

A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans

NCT01981928

Phase 1 Completed 48 enrolled Astellas Pharma Europe B.V.
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of the study is to see how safe the study drug is and how well it is tolerated after dosing. The study will also investigate how the study drug is taken up, metabolized (chemically broken down), distributed through the body and excreted. A further aim is to look at how this process is possibly altered by food by giving the study drug in the presence and absence of meals.

Timeline

Start
2013-11
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP7962 Small molecule Oral

Indications

No indication recorded.